Jazz Pharmaceuticals JAZZ Deferred Income Tax Expense (Benefit), Before Effect Of Change In Tax Rates

Deferred Income Tax Expense (Benefit), Before Effect Of Change In Tax Rates at other companies

Willis Towers WatsonWTW

-$30M-30.4%

Applied OptoelectronicsAAOI

$1.05M—

Two Harbors Investment CorporationTWO

——

PopularBPOP

——

PopularBPOP

——

Two Harbors Investment CorporationTWO

——

Questions, answered.

What is Jazz Pharmaceuticals's deferred income tax expense (benefit), before effect of change in tax rates?

Jazz Pharmaceuticals (JAZZ) reported deferred income tax expense (benefit), before effect of change in tax rates of -$110.72M in Q4 2025.

How has Jazz Pharmaceuticals's deferred income tax expense (benefit), before effect of change in tax rates changed year-over-year?

Jazz Pharmaceuticals's deferred income tax expense (benefit), before effect of change in tax rates decreased by 111.6% year-over-year, from -$52.32M to -$110.72M.

What is the long-term trend for Jazz Pharmaceuticals's deferred income tax expense (benefit), before effect of change in tax rates?

Over 4 years (2021 to 2025), Jazz Pharmaceuticals's deferred income tax expense (benefit), before effect of change in tax rates has grown at a 23.2% compound annual growth rate (CAGR), from -$192.06M to -$442.9M.

What does deferred income tax expense (benefit), before effect of change in tax rates mean?

The tax impact of temporary differences before accounting for changes in tax rates.

How do you interpret deferred income tax expense (benefit), before effect of change in tax rates?

A large benefit suggests significant reversal of deferred tax liabilities or creation of deferred tax assets, often due to capital investments or R&D credits.

How does deferred income tax expense (benefit), before effect of change in tax rates compare across companies?

Standard line item for all corporations reporting under GAAP/IFRS.